SECsense Logo

Charles River Laboratories 8-K Report: Key Updates & Insights for Investors

$CRL
Form 8-K
Filed on: 2025-02-19
Source
Charles River Laboratories 8-K Report: Key Updates & Insights for Investors

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Charles River Laboratories International, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK (Central Index Key): 0001100682
  • SEC File Number: 001-15943
  • Employer Identification Number (EIN): 06-1397316
  • Address: 251 Ballardvale Street, Wilmington, MA 01887
  • Phone Number: 781-222-6000
  1. Security Information:
  • Type of Security: Common stock
  • Par Value: $0.01
  • Ticker Symbol: CRL
  • Exchange: NYSE (New York Stock Exchange)
  1. Filing Information:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: February 19, 2025
  1. Reporting Period:
  • Start Date: February 19, 2025
  • End Date: February 19, 2025
  1. XML Metadata:
  • The report is formatted in XBRL (eXtensible Business Reporting Language), which is often used for financial reporting to ensure the data can be easily processed and analyzed.

Summary:

This report indicates that Charles River Laboratories International, Inc. filed an 8-K report on February 19, 2025, which may contain important updates or disclosures relevant to investors. The company is publicly traded on the NYSE under the ticker CRL, and it operates out of Wilmington, MA. The filing is relevant for stakeholders looking for recent developments concerning the company's operations or financial status.